Physician

John C Shin, M.D.

According to 2025 Medicare claims, John Shin, M.D. (NPI: 1114920477) practices ophthalmology in the San Rafael, CA market, with the plurality of this provider's patient population coming from Marin, CA. This provider's primary affiliated billing organization is MARIN OPHTHALMIC CONSULTANTS, A MEDICAL CORPORATION (NPI: 1447253919; TIN: 942778154) and primary practice location at 94901-2850.

Shin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,734 traditional Medicare patients, billed 5,460 HCPCS/CPT codes, and received $517,996 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,079 prescription claims across 545 beneficiaries totaling $266,185 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 4 records totaling $84. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $759,365 to $517,996. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$380K$759K2015 Medicare payment: $759,365 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $664,705 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $660,280 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $697,146 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $622,110 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $416,161 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $519,834 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $489,574 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $506,648 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $517,996 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153,3347,287$759,365
20163,2357,050$664,705
20173,0486,864$660,280
20183,1706,867$697,146
20193,0566,451$622,110
20202,2764,323$416,161
20212,7245,453$519,834
20222,7775,462$489,574
20232,7825,438$506,648
20242,7345,460$517,996

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$197K$395K2015 Drug cost: $289,334 (USD; Tot_Drug_Cst)2016 Drug cost: $328,633 (USD; Tot_Drug_Cst)2017 Drug cost: $366,091 (USD; Tot_Drug_Cst)2018 Drug cost: $386,895 (USD; Tot_Drug_Cst)2019 Drug cost: $394,762 (USD; Tot_Drug_Cst)2020 Drug cost: $315,051 (USD; Tot_Drug_Cst)2021 Drug cost: $325,897 (USD; Tot_Drug_Cst)2022 Drug cost: $353,921 (USD; Tot_Drug_Cst)2023 Drug cost: $304,549 (USD; Tot_Drug_Cst)2024 Drug cost: $266,185 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20156823,099$289,334
20166953,149$328,633
20177063,198$366,091
20187423,302$386,895
20196833,017$394,762
20205842,426$315,051
20216462,329$325,897
20226302,422$353,921
20236222,215$304,549
20245452,079$266,185

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system1,1631,200$104
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,3351,798$73
92083Exam of visual field with extended testing378382$56
92134Imaging of retina331337$36
92133Imaging of optic nerve502505$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost1519,057$84,514
RestasisCyclosporine281,380$28,658
XiidraLifitegrast15990$21,789
Timolol MaleateTimolol Maleate19513,520$14,839
Alphagan PBrimonidine Tartrate221,230$12,823

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$84Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John C. Shin, M.D.?

Tedicare shows public-source Medicare data for John C. Shin, M.D. (NPI 1114920477), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John C. Shin, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John C. Shin, M.D.?

John C. Shin, M.D. is linked to MARIN OPHTHALMIC CONSULTANTS, A MEDICAL CORPORATION (billing NPI 1447253919) in the available physician profile data.

Does John C. Shin, M.D. have Open Payments data?

John C. Shin, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.